Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141,008 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of the long-acting fusion inhibitor albuvirtide in antiretroviral-experienced adults with human immunodeficiency virus-1: interim analysis of the randomized, controlled, phase 3, non-inferiority TALENT study.
Su B, Yao C, Zhao QX, Cai WP, Wang M, Lu HZ, Chen YY, Liu L, Wang H, He Y, Zheng YH, Li LH, Chen JF, Yu JH, Zhu B, Zhao M, Sun YT, Lun WH, Xia W, Sun LJ, Dai LL, Jiang TY, Wang MX, Zheng QS, Peng HY, Wang Y, Lu RJ, Hu JH, Xing H, Shao YM, Xie D, Zhang T, Zhang FJ, Wu H; TALENT Study Team. Su B, et al. Among authors: wang h, wang mx, wang y, wang m. Chin Med J (Engl). 2020 Nov 25;133(24):2919-2927. doi: 10.1097/CM9.0000000000001273. Chin Med J (Engl). 2020. PMID: 33252379 Free PMC article. Clinical Trial.
Consensus statement on human immunodeficiency virus pre-exposure prophylaxis in China.
Xu JJ, Huang XJ, Liu XC, Wang LM, Chen YK, Wang H, Zhang FJ, Wu H, Li TS, Han MJ, Zhao F, Ding HB, Duan JY, Sheng GS, Shang H. Xu JJ, et al. Among authors: wang h, wang lm. Chin Med J (Engl). 2020 Dec 5;133(23):2840-2846. doi: 10.1097/CM9.0000000000001181. Chin Med J (Engl). 2020. PMID: 33273333 Free PMC article. No abstract available.
Long-acting HIV fusion inhibitor albuvirtide combined with ritonavir-boosted lopinavir for HIV-1-infected patients after failing the first-line antiretroviral therapy: 48-week randomized, controlled, phase 3 non-inferiority TALENT study.
Su B, Yao C, Zhao QX, Cai WP, Wang M, Lu HZ, Mu TT, Chen YY, Liu L, Wang H, He Y, Zheng YH, Li LH, Chen JF, Yu JH, Zhu B, Zhao M, Sun YT, Lun WH, Zhang YH, Wang H, Xia W, Sun LJ, Dai LL, Jiang TY, Wang MX, Zheng QS, Peng HY, Wang Y, Hu M, Liu X, Lu RJ, Hu JH, Sun CC, Xing H, Shao YM, Xie D, Zhang T, Zhang FJ, Wu H. Su B, et al. Among authors: wang h, wang mx, wang y, wang m. J Infect. 2022 Sep;85(3):334-363. doi: 10.1016/j.jinf.2022.05.034. Epub 2022 Jun 1. J Infect. 2022. PMID: 35659547 No abstract available.
Burden of sleep disturbances and associated risk factors: A cross-sectional survey among HIV-infected persons on antiretroviral therapy across China.
Huang X, Li H, Meyers K, Xia W, Meng Z, Li C, Bai J, He S, Cai W, Huang C, Liu S, Wang H, Ling X, Ma P, Tan D, Wang F, Ruan L, Zhao H, Wei H, Liu Y, Yu J, Lu H, Wang M, Zhang T, Chen H, Wu H. Huang X, et al. Among authors: wang h, wang f, wang m. Sci Rep. 2017 Jun 16;7(1):3657. doi: 10.1038/s41598-017-03968-3. Sci Rep. 2017. PMID: 28623361 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 33093282
[No title available]
[No authors listed] [No authors listed] PMID: 33177395
Evolution of blood lipids and risk factors of dyslipidemia among people living with human immunodeficiency virus who had received first-line antiretroviral regimens for 3 years in Shenzhen.
Sun LQ, Liu JY, He Y, Zhou Y, Xu LM, Zhang LK, Zhao F, Liu XN, Song Y, Cao TZ, Tian YM, Rao M, Wang H. Sun LQ, et al. Among authors: wang h. Chin Med J (Engl). 2020 Dec 5;133(23):2808-2815. doi: 10.1097/CM9.0000000000001245. Chin Med J (Engl). 2020. PMID: 33273329 Free PMC article.
141,008 results
You have reached the last available page of results. Please see the User Guide for more information.